However, interactions involving TAMs signalling to malignant cells expressing CD44 via SPP1 and MIF, known to suppress T‐cell activation and promote TAM secretion of growth factors respectively,68, 69 decreased after therapy (Figure 7D), suggesting a transformation towards an anti‐tumour microenvironment. Here, CD44 is linked to neoplasm.